The Food and Drug Administration (FDA) is announcing the renewal of the Gastrointestinal Drugs Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Gastrointestinal Drugs Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until March 3, 2018.
Document
Advisory Committee; Gastrointestinal Drugs Advisory Committee, Renewal
The Food and Drug Administration (FDA) is announcing the renewal of the Gastrointestinal Drugs Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The C...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
81 FR 9864
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Advisory Committee; Gastrointestinal Drugs Advisory Committee, Renewal,” thefederalregister.org (February 26, 2016), https://thefederalregister.org/documents/2016-04093/advisory-committee-gastrointestinal-drugs-advisory-committee-renewal.